The Biggest, Buzziest Conference for Health Care Investors Convenes Amid Fears the Bubble Will Burst


SAN FRANCISCO — Well being care’s enterprise class returned to its San Francisco sanctuary final week for JPMorgan’s annual well being care confab, on the gilded Westin St. Francis resort on Union Sq.. After a two-year pandemic pause, the temper among the many executives, bankers, and startup founders in attendance had the aura of a reunion — as they gossiped about promotions, work-from-home routines, who’s getting what investments. Dressed of their capitalist greatest — starting from brilliant-blue or pastel-purple blazers to puffy-coat stylish — they thronged to large events, housed in artwork galleries or eating places.

However the get together was tinged with new nervousness: Would the large cash invested in well being care attributable to covid-19 proceed to move? Would traders ask to see outcomes — which means earnings — relatively than simply cool concepts?

The buzzy convention had simply as many phrases about earnings as about sufferers. The largely maskless crowd spoke English, French, Japanese — and, after all, cash.

Apart from the company and funding sorts, attendees routinely noticed shocking characters — like superstar physician Mehmet Oz, recent off a Senate run, holding courtroom within the foyer on Jan. 10.

If the vibe within the resort’s congested halls was upbeat — or, a minimum of, cheery — beneath there was a frisson of tension as all have been conscious that the well being care enterprise bonanza seemed to be slowing down.

The convention began with a sidewalk protest of pharmaceutical firm Gilead Sciences, whose medicine combating HIV and hepatitis C are fabulously efficient — and fabulously costly. Throughout the pandemic, Congress for the primary time has arrange a plan to permit Medicare to barter U.S. drug costs, that are by far the very best on the planet. In a press release, firm spokesperson Catherine Cantone stated Gilead is the biggest personal funder of HIV applications within the U.S., including, “Gilead’s position in ending the HIV and hepatitis epidemics is to find, develop, and guarantee entry to our life-saving medicines.”

Then there’s the financial atmosphere, which is popping treacherous. Journalists at monetary publication Bloomberg recognized a scarcity of thrilling offers. Startup executives — who beforehand discovered tens of millions of {dollars} in investments simple to return by — appeared obligated to indicate ends in their impromptu pitches in bars and low outlets. Enterprise executives of all stripes promised they both presently made earnings or have been about to, quickly.

“I believe this can be a difficult yr,” stated Hemant Taneja, CEO of the enterprise capital agency Basic Catalyst, throughout one panel. He urged that enormous swaths of well being tech startups have been overvalued and that their shoppers will likely be extra enthusiastic about whether or not they’re truly offering helpful companies.

The brand new message from potential traders was clear. “The thought you may develop and never be worthwhile is useless, gone,” stated Dr. Jon Cohen, CEO of the psychological well being startup Talkspace, in an interview.

There was some cognitive dissonance on the convention. Take, for instance, BioNTech, the vaccine developer whose mRNA vaccine, created with Pfizer, supplies highly effective safety for covid. Firm co-founder Uğur Şahin was interrupted by applause throughout a presentation recounting its position in combating the pandemic — and that’s earlier than he touted his firm’s position in decreasing infectious illness, saving lives, and assembly international well being wants for tuberculosis and malaria.

The dialog later turned to the pricing of his firm’s flagship vaccine — which it’s jockeying to set at greater than $100 a dose, up from a median authorities buy worth of $20.69. It was a good worth contemplating the “well being economics,” BioNTech’s chief technique officer, Ryan Richardson, defined: the hospitalizations and critical outcomes averted.

Or take drugstore big CVS — which is steadily increasing past its retail roots into medical health insurance and first care. CVS Well being CEO Karen Lynch stated that as a part of its well being enterprise the corporate is taking a look at all of the components that underlie being properly. “Well being isn’t simply in regards to the engagement with the supplier; it’s about all the opposite components — together with housing and vitamin,” she stated. Left unaddressed was the sight usually greeting CVS clients upon getting into a retailer: sweet, chips, and different processed meals.

For critics, it was a mind-bending remark. “The final I heard, CVS was a for-profit firm, not a social welfare company,” stated Marion Nestle, a researcher who’s a longtime critic of the meals trade. “It sells junk meals that make individuals sick and medicines to deal with these diseases. How’s that for a nifty enterprise mannequin!”

CVS spokesperson Ethan Slavin provided a really completely different imaginative and prescient, one wherein CVS is searching for to be a premier well being and wellness vacation spot. “We’re at all times evolving our meals and beverage assortment to supply more healthy, on-trend merchandise.” It’s also supporting applications to bolster meals availability in underserved areas, he added.

Some techies encountered new skepticism about “synthetic intelligence.” Ginkgo Bioworks co-founder Jason Kelly famous throughout his presentation that individuals on the convention heard a lot about synthetic intelligence in the course of the conferences, “they wish to cease listening to it.” (Ginkgo’s AI, used to assist pharmaceutical and biotech analysis, he stated, was completely different than the remaining.)

One surgeon, Dr. Rajesh Aggarwal, discovered conversations with financiers in regards to the stealth startup he based, which focuses on metabolic well being, have been targeted on silver bullets. “Inform me if I make investments on this, I’ll 10x” the outlay, he stated, paraphrasing the bankers. Many, he stated, wished to “do some good as properly” for sufferers.

Aggarwal felt the traders have been on the lookout for easy options to well being issues. And one merchandise match that invoice: a brand new class of medication — GLP-1 agonists, a kind of treatment that aids in weight reduction however will seemingly should be taken for lengthy intervals. Some analysts are projecting these medicine will likely be value $50 billion. The bankers, Aggarwal felt, aren’t “excited about well being care,” they’re “excited about the {dollars} connected to the tablet.”

KHN (Kaiser Well being Information) is a nationwide newsroom that produces in-depth journalism about well being points. Along with Coverage Evaluation and Polling, KHN is likely one of the three main working applications at KFF (Kaiser Household Basis). KFF is an endowed nonprofit group offering data on well being points to the nation.


This story might be republished without cost (particulars).


Please enter your comment!
Please enter your name here